True North Therapeutics

Acquired

Sanofi Pharmaceuticals - Healthcare Innovations | Sanofi USA

South San Francisco, United States · Founded 2013 · $142.0M raised

Employees
11–50
Founded
2013
Business Model
B2B
Website
sanofi.us
Total Funding
$142.0M
Last Round
$45.0M Series DOct 2016
Rounds
4
Acquisition Date
May 2017

About

True North Therapeutics is a biotechnology company that selectively inhibits the Complement pathway for diseases of high unmet clinical need. Its lead monoclonal antibody, TNT009, targets the Classical Complement pathway so downstream phagocytosis, inflammation, and cell lysis can be blocked. The company focuses on Complement-mediated rare diseases in the hematologic, renal, and neurological space. True North was formed in 2013 as a spin-out of iPierian.

Summary

True North Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2013. It has raised $142.0M in total across 4 rounds, most recently a $45.0M Series D round in Oct 2016. Investors include OrbiMed, Baxter Ventures and MPM Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

AcquisitionMay 2017

Sign up to see all 5 rounds

Series A through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

True North Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/true-north-therapeutics"><img src="https://indexed.vc/api/badge/company/true-north-therapeutics" alt="True North Therapeutics on Indexed.vc" width="260" height="76" /></a>